In this issue:
Treatment of Helicobacter pylori infection guidelines
Clinical Practice Guidelines for genetic cholestatic liver diseases
Quality indicators for colonoscopy
How to address conflict between parents, physicians and healthcare professionals
Opioids and the gastrointestinal tract
Drug-induced cholestatic liver diseases
Pharmacologic therapies for reducing liver fat content in MASH
Pharmaceutical Benefits Advisory Committee September recommendations
Medicare Benefits Schedule amendment to MRI item
COVID-19 may be causing an increase in surgical deaths
Blood test for colorectal cancer screening has limitations
Liver transplantation provides survival benefit at all frailty levels
Nominations for TSANZ Directors
Please login below to download this issue (PDF)